Correlation Between Scandinavian ChemoTech and OMX Stockholm

Can any of the company-specific risk be diversified away by investing in both Scandinavian ChemoTech and OMX Stockholm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scandinavian ChemoTech and OMX Stockholm into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Scandinavian ChemoTech AB and OMX Stockholm Mid, you can compare the effects of market volatilities on Scandinavian ChemoTech and OMX Stockholm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scandinavian ChemoTech with a short position of OMX Stockholm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scandinavian ChemoTech and OMX Stockholm.

Diversification Opportunities for Scandinavian ChemoTech and OMX Stockholm

0.44

Correlation Coefficient

Scandinavian ChemoTech  OMX Stockholm

Very weak diversification

The 3 months correlation between Scandinavian and OMX is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Scandinavian ChemoTech AB and OMX Stockholm Mid in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OMX Stockholm Mid and Scandinavian ChemoTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scandinavian ChemoTech AB are associated (or correlated) with OMX Stockholm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OMX Stockholm Mid has no effect on the direction of Scandinavian ChemoTech i.e., Scandinavian ChemoTech and OMX Stockholm go up and down completely randomly.

Pair Corralation between Scandinavian ChemoTech and OMX Stockholm

Assuming the 90 days trading horizon Scandinavian ChemoTech AB is expected to under-perform the OMX Stockholm. In addition to that, Scandinavian ChemoTech is 7.85 times more volatile than OMX Stockholm Mid. It trades about -0.03 of its total potential returns per unit of risk. OMX Stockholm Mid is currently generating about -0.12 per unit of volatility. If you would invest  165,737  in OMX Stockholm Mid on October 12, 2024 and sell it today you would lose (2,664) from holding OMX Stockholm Mid or give up 1.61% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Scandinavian ChemoTech AB  vs.  OMX Stockholm Mid

Pair Trading with Scandinavian ChemoTech and OMX Stockholm

The main advantage of trading using opposite Scandinavian ChemoTech and OMX Stockholm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scandinavian ChemoTech position performs unexpectedly, OMX Stockholm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OMX Stockholm will offset losses from the drop in OMX Stockholm's long position.

The idea behind Scandinavian ChemoTech AB and OMX Stockholm Mid pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.